Managing fragility fractures during the COVID-19 pandemic

The COVID-19 pandemic has broad implications for the care of patients with bone fragility. A dramatic surge in fractures and related mortality is expected in the next few months. We pledge to intensify the current efforts to improve the management of bone health, and to prioritize fragility fracture...

Descripción completa

Detalles Bibliográficos
Autores principales: Napoli, Nicola, Elderkin, Ann L., Kiel, Douglas P., Khosla, Sundeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288256/
https://www.ncbi.nlm.nih.gov/pubmed/32528045
http://dx.doi.org/10.1038/s41574-020-0379-z
_version_ 1783545236688994304
author Napoli, Nicola
Elderkin, Ann L.
Kiel, Douglas P.
Khosla, Sundeep
author_facet Napoli, Nicola
Elderkin, Ann L.
Kiel, Douglas P.
Khosla, Sundeep
author_sort Napoli, Nicola
collection PubMed
description The COVID-19 pandemic has broad implications for the care of patients with bone fragility. A dramatic surge in fractures and related mortality is expected in the next few months. We pledge to intensify the current efforts to improve the management of bone health, and to prioritize fragility fracture care and prevention.
format Online
Article
Text
id pubmed-7288256
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72882562020-06-11 Managing fragility fractures during the COVID-19 pandemic Napoli, Nicola Elderkin, Ann L. Kiel, Douglas P. Khosla, Sundeep Nat Rev Endocrinol Comment The COVID-19 pandemic has broad implications for the care of patients with bone fragility. A dramatic surge in fractures and related mortality is expected in the next few months. We pledge to intensify the current efforts to improve the management of bone health, and to prioritize fragility fracture care and prevention. Nature Publishing Group UK 2020-06-11 2020 /pmc/articles/PMC7288256/ /pubmed/32528045 http://dx.doi.org/10.1038/s41574-020-0379-z Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Napoli, Nicola
Elderkin, Ann L.
Kiel, Douglas P.
Khosla, Sundeep
Managing fragility fractures during the COVID-19 pandemic
title Managing fragility fractures during the COVID-19 pandemic
title_full Managing fragility fractures during the COVID-19 pandemic
title_fullStr Managing fragility fractures during the COVID-19 pandemic
title_full_unstemmed Managing fragility fractures during the COVID-19 pandemic
title_short Managing fragility fractures during the COVID-19 pandemic
title_sort managing fragility fractures during the covid-19 pandemic
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288256/
https://www.ncbi.nlm.nih.gov/pubmed/32528045
http://dx.doi.org/10.1038/s41574-020-0379-z
work_keys_str_mv AT napolinicola managingfragilityfracturesduringthecovid19pandemic
AT elderkinannl managingfragilityfracturesduringthecovid19pandemic
AT kieldouglasp managingfragilityfracturesduringthecovid19pandemic
AT khoslasundeep managingfragilityfracturesduringthecovid19pandemic

Ejemplares similares